Alps Advisors Inc Biotechnology

Alps Advisors Inc

$17.2 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NUVB Nuvation Bio Inc.	$1.12B	$356,000 0.0% of portfolio	183,035	Q2 2025 Reduced 25.33%
DAWN Day One Biopharmaceuticals, Inc.	$537M	$355,000 0.0% of portfolio	54,708	Q2 2025 Reduced 25.41%
ADMA Adma Biologics, Inc.	$3.04B	$354,000 0.0% of portfolio	19,484	Q2 2025 Added 1.23%
IMTX Immatics N.V.	$738M	$352,000 0.0% of portfolio	65,582	Q2 2025 New
TRVI Trevi Therapeutics, Inc.	$629M	$351,000 0.0% of portfolio	64,294	Q2 2025 New
URGN Uro Gen Pharma Ltd.	$460M	$340,000 0.0% of portfolio	24,839	Q2 2025 Reduced 24.18%
HRMY Harmony Biosciences Holdings, Inc.	$1.82B	$334,000 0.0% of portfolio	10,601	Q2 2025 Added 1.22%
STOK Stoke Therapeutics, Inc.	$1.03B	$334,000 0.0% of portfolio	29,430	Q2 2025 Reduced 26.22%
AUTL Autolus Therapeutics PLC	$135M	$327,000 0.0% of portfolio	143,614	Q2 2025 Reduced 28.09%
UTHR United Therapeutics Corp	$19.9B	$324,000 0.0% of portfolio	1,130	Q2 2025 Added 1.25%
RLAY Relay Therapeutics, Inc.	$825M	$320,000 0.0% of portfolio	92,528	Q2 2025 New
XNCR Xencor Inc	$832M	$301,000 0.0% of portfolio	38,399	Q2 2025 Reduced 25.38%
HALO Halozyme Therapeutics, Inc.	$9.48B	$299,000 0.0% of portfolio	5,756	Q2 2025 Added 1.23%
TBPH Theravance Biopharma, Inc.	$1.02B	$297,000 0.0% of portfolio	27,007	Q2 2025 Reduced 25.14%
KROS Keros Therapeutics, Inc.	$392M	$293,000 0.0% of portfolio	21,949	Q2 2025 Reduced 26.19%
MDXG Mimedx Group, Inc.	$871M	$282,000 0.0% of portfolio	46,237	Q2 2025 Added 3.46%
REGN Regeneron Pharmaceuticals, Inc.	$67.3B	$281,000 0.0% of portfolio	536	Q2 2025 Added 1.13%
BMRN Biomarin Pharmaceutical Inc	$9.76B	$279,000 0.0% of portfolio	5,081	Q2 2025 Added 1.24%
TYRA Tyra Biosciences, Inc.	$640M	$274,000 0.0% of portfolio	28,729	Q2 2025 New
CELC Celcuity Inc.	$1.1B	$272,000 0.0% of portfolio	20,391	Q2 2025 Reduced 29.19%
KURA Kura Oncology, Inc.	$654M	$269,000 0.0% of portfolio	46,660	Q2 2025 New
CAPR Capricor Therapeutics, Inc.	$153M	$244,000 0.0% of portfolio	24,671	Q2 2025 Reduced 25.76%
RGNX Regenxbio Inc.	$518M	$222,000 0.0% of portfolio	27,045	Q2 2025 New
ITOS I Teos Therapeutics, Inc.	$361M	$205,000 0.0% of portfolio	20,653	Q2 2025 Reduced 27.9%
RZLT Rezolute, Inc.	$346M	$205,000 0.0% of portfolio	46,105	Q2 2025 Added 7.01%
ERAS Erasca, Inc.	$291M	$194,000 0.0% of portfolio	152,827	Q2 2025 Reduced 27.32%
CMPX Compass Therapeutics, Inc.	$372M	$193,000 0.0% of portfolio	74,597	Q2 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$247M	$190,000 0.0% of portfolio	14,619	Q2 2025 Reduced 26.72%
BCYC Bicycle Therapeutics PLC	$215M	$179,000 0.0% of portfolio	25,757	Q2 2025 New
PRTA Prothena Corp Public LTD CO	$481M	$176,000 0.0% of portfolio	29,028	Q2 2025 Reduced 23.52%
TERN Terns Pharmaceuticals, Inc.	$660M	$175,000 0.0% of portfolio	47,156	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$271M	$166,000 0.0% of portfolio	46,165	Q2 2025 New
ATXS Astria Therapeutics, Inc.	$186M	$163,000 0.0% of portfolio	30,424	Q2 2025 Reduced 29.97%
OLMA Olema Pharmaceuticals, Inc.	$336M	$157,000 0.0% of portfolio	36,910	Q2 2025 Reduced 26.89%
GOSS Gossamer Bio, Inc.	$225M	$150,000 0.0% of portfolio	122,644	Q2 2025 New
VNDA Vanda Pharmaceuticals Inc.	$253M	$149,000 0.0% of portfolio	31,759	Q2 2025 Reduced 24.37%
ANNX Annexon, Inc.	$149M	$142,000 0.0% of portfolio	59,201	Q2 2025 Reduced 28.35%
CADL Candel Therapeutics, Inc.	$148M	$136,000 0.0% of portfolio	27,045	Q2 2025 New
YMAB Y M Abs Therapeutics, Inc.	$376M	$110,000 0.0% of portfolio	24,429	Q2 2025 Reduced 26.66%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	53,000	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.